Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2023 Jan 20;86(4):415–416. doi: 10.1016/j.jinf.2023.01.020

Changes in the prevalence of infectious diseases before and after the COVID-19 pandemic in Pakistan

Muhammad Suleman Rana a,, Muhammad Usman a, Muhammad Masroor Alam a, Muhammad Tahir d, Aamer Ikram a, Syed Sohail Zahoor Zaidi a, Muqarrab Kashif c, Umair Massab a, Rani Faryal b, Muhammad Anas a, Nadeem Ullah a, Muhammad Salman a
PMCID: PMC9852260  PMID: 36682628

Dear Editor,

We read with immense interest a recent article entitled “changes of staphylococcus aureus infection in children before and after the COVID-19 pandemic, Henan, China” by Ying Liang and colleagues.1 The authors reported a declining rate of staphylococcus aureus infection in children in response to the COVID-19 pandemic in China. In a similar context, we would like to present the data on the percentage change in the incidence of multiple infectious diseases before and after the COVID-19 pandemic in Pakistan.

Infectious diseases remain one of the leading causes of morbidity and mortality around the world accounting for more than 52 million (33%) annual deaths worldwide. Half of the world's population remains at risk of emerging and re-emerging infectious diseases. The recent figures indicate an estimated 14 million global deaths in children less than 5 years of age, 70% of which resulted from vaccine-preventable diseases and 99% reported in developing countries.2 Despite significant advances and awareness programs launched at a global scale, the prevention and control of infectious diseases face major challenges. Many infectious diseases are common in Pakistan with marginal changes in their case burden and endemicity observed over decades.3

Limited research studies have been conducted in Pakistan to investigate the potential impact of the COVID-19 pandemic on priority infectious diseases. This study highlights the overall impact of the COVID-19 pandemic on the prevalence of endemic infectious diseases in Pakistan supported by data available before and after the COVID-19 pandemic.

The data source utilized for the present study is based on the surveillance records available at the National Institute of Health (NIH) Islamabad, which is the only national public health institute supporting disease surveillance and epidemiology programs across the country. For comparative analysis, we extracted the number of suspected cases reported between January 2019 and December 2022. Twenty infectious diseases including TB, Measles, Rubella, Influenza, RSV, Pertussis, Diphtheria, Leishmania, EBV, Pneumonia, Haemophilus Influenza, VZV, Mumps, Dengue, Malaria, Polio, Typhoid, Hepatitis, HIV, and diarrhea are notifiable in Pakistan. Between 01 January 2019 and 31 December 2022, a total of 13,666,263 cases of 20 infectious diseases were reported across Pakistan.

Overall, a 28% decline in suspected cases of 20 infectious diseases was noticed from 1,995,247 in 2019 to 1,436,772 reported cases during the pandemic period,4 with an exceptional increase in a case count of only three diseases including typhoid, hepatitis, and HIV. In contrast, the situation completely reversed after the pandemic subsided, with a 259.4% increase in the number of reported cases (2,227,613 cases in 2021 and 8,006,631 cases reported in 2022), mainly of five diseases including Mumps (2656% rise), malaria (990% rise), polio (2100% rise), influenza (354% rise) and diphtheria (419% rise) (Table 1 ).

Table 1.

Number of reported cases of infectious diseases during January 2019 to December 2022.

Diseases % Change in 2019-2020
% Change in 2021-2022
2019 2020 % Change 2021 2022 % Change
TB 178767 87358 -51.1 340000 410000 20.6
Measles 7783 6485 -16.7 20867 22725 8.9
Rubella 6552 4877 -25.6 7543 8413 11.5
Influenza 417 87 -79.1 715 3248 354.3
RSV 320 21 -93.4 619 1723 178.4
Pertussis 624 35 -94.4 57 107 87.7
Diphtheria 832 157 -81.1 213 1106 419.2
Leishmania 22114 12587 -43.1 16865 27272 61.7
EBV 73 11 -84.9 31 47 51.6
Pneumonia 1302 248 -81.0 723 2317 220.5
Haemophilus Influenza 209 37 -82.3 87 318 265.5
VZV 523 114 -78.2 308 614 99.4
Mumps 258 39 -84.9 719 19816 2656.1
Dengue 52485 6455 -87.7 50120 77879 55.4
Malaria 542960 375135 -30.9 463240 5050565 990.3
Polio 147 84 -42.9 1 22 2100.0
Typhoid 7673 22537 193.7 174698 365248 109.1
Hepatitis 120509 164652 36.6 189513 234107 23.5
HIV 3241 18000 455.4 25657 27652 7.8
Diarrhea 1048458 737853 -29.6 935637 1753452 87.4
Total 1995247 1436772 -28.0 2227613 8006631 259.4

TB: Tuberculosis, RSV: Respiratory syncytial virus, EBV: Epstein bar virus, VZV: Varicella zoster virus, HIV: Human Immunodeficiency Virus

The declining trend in the incidence of infectious diseases during the pandemic period has been reported in various countries including China,5 , 6 owing to the implementation of COVID-19 preventative measures, such as the use of face masks, hand washing, social distancing, a ban on public gatherings, closure of shopping malls, educational institutes, and lockdown. However, the under-reporting during the pandemic as well as the shift in resources towards the COVID-19 pandemic contributed to this decline. In a local country's context, there are multiple reasons behind the surge of infectious diseases in Pakistan mainly the recent extreme flooding in the country. Due to the devastating flood in 2022, the increase in vector-borne diseases including dengue and malaria was expected, but the increase in vaccine-preventable diseases provides evidence of disruption in immunization during the COVID-19 pandemic and currently due to extreme flooding. The annual coverage of routine immunization in Pakistan remains far below the optimal coverage of 95% as recommended by the WHO,7 the COVID-19 pandemic and recent floods made the bad situation worse.

The finding of the study showed that the COVID-19 pandemic as well as climatic change have adversely impacted the control and prevention of infectious diseases in Pakistan. Effective surveillance and high immunization coverage remain the topline strategies for the control of such deadly threats. However, the biased utilization of already limited resources available in the country to control the COVID-19 pandemic further deteriorated the targets required for infectious disease control. We may thus recommend formalizing a rationale and comprehensive preparedness plan to generate, allocate, and wise utilization of resources. This gets extremely critical for countries like Pakistan which are prone to natural calamities like flooding, earthquakes, and droughts. Despite these interventions, political commitment is consistently required to improve and strengthen the fragile healthcare systems and surveillance programs in low- and middle-income countries including Pakistan because communicable diseases do not respect geographical boundaries.

Authors contributions

MSR, MU, MMA, AI, MS and SSZZ designed the study. MSR, M Umair, MMA collected data and analysis. MSR, MU and MMA wrote the manuscript draft.

Funding

No funding source.

Declaration of Competing Interest

All author declared that there is no conflict of interest.

Acknowledgements

The authors extend their gratitude to the diseases epidemiology and surveillance staff of National Institute of Health Islamabad for their support.

References

  • 1.Liang Y., Li J., Hou L., Zhang X., Hou G., Zhang W., et al. Changes of Staphylococcus aureus infection in children before and after the COVID-19 pandemic, Henan, China. J Infect. 2022;S0163-4453(22):00751–00754. doi: 10.1016/j.jinf.2022.12.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Frenkel L.D. Proceedings of the allergy and asthma. OceanSide Publications, Inc; 2021. The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: implications for COVID-19 vaccination. How can we do better? [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Rana M.S., Usman M., Alam M.M., Ikram A., Salman M. Overlapping clinical manifestations of COVID-19 with endemic infectious diseases in Pakistan: a looming threat of multiple lethal combinations. Infect Ecol Epidemiol. 2021;11(1) doi: 10.1080/20008686.2021.1873494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Rana M.S., Usman M., Alam M.M., Ikram A., Salman M., Zaidi S.S. Impact of COVID-19 preventive measures on other infectious and non-infectious respiratory diseases in Pakistan. J Infect. 2021;82(5):e31–e32. doi: 10.1016/j.jinf.2021.01.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Liang Y., Zhang P., Du B., Zhang X., Hou G., Zhang W. Changes of Mycoplasma pneumonia infection in children before and after the COVID-19 pandemic, Henan, China. J Infect. 2022 doi: 10.1016/j.jinf.2022.12.015. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zhang M., Gao J., Guo Q., Zhang X., Zhang W. Changes of respiratory syncytial virus infection in children before and after the COVID-19 pandemic in Henan, China. J Infect. 2022 doi: 10.1016/j.jinf.2022.12.011. ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Rana M.S., Usman M., Alam M.M., Ikram A., Salman M., Umair M. The world's largest measles-Rubella vaccination campaign in Pakistan: time to invest in routine immunization. Hum Vaccines Immunother. 2022;18(5) doi: 10.1080/21645515.2022.2080444. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Infection are provided here courtesy of Elsevier

RESOURCES